Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2017

Open Access 01-12-2017 | Research article

Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study

Authors: Chanchira Phosat, Pornpimol Panprathip, Noppanath Chumpathat, Pattaneeya Prangthip, Narisara Chantratita, Ngamphol Soonthornworasiri, Somchai Puduang, Karunee Kwanbunjan

Published in: BMC Endocrine Disorders | Issue 1/2017

Login to get access

Abstract

Background

The elevated levels of inflammatory markers, including C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), and interleukin 6 (IL6) are supposed to be associated with type 2 diabetes mellitus (T2DM). Frequent high glycemic load (GL) consumption, central obesity, and a lack of physical activity are considered to be T2DM risk factors. This study aimed to determine the difference of these inflammatory markers as well as GL in individuals with versus those without T2DM in rural Thais.

Methods

A total of 296 participants aged 35–66 living in Sung Noen District, Nakhon Ratchasima Province, Thailand, were recruited. Blood was collected to evaluate blood glucose levels, lipid profiles, and inflammatory markers. A Semi-food frequency questionnaire was utilized to assess GL followed by socioeconomic and anthropometric assessment. Statistical analysis was subsequently performed.

Results

Elevated CRP and IL6 levels were associated with increased risk of developing T2DM [OR (95% CI): 7.51 (2.11, 26.74) and 4.95 (1.28, 19.11)], respectively. There was a trend towards increased risk of T2DM with elevated TNF-α levels [OR (95% CI): 1.56 (0.39, 6.14)]. GL correlated significantly with fasting blood glucose (r = 0.289, P = 0.016), suggesting that it is involved in T2DM in this study group.

Conclusion

In this study, CRP, IL6, and TNF-α associated with T2DM. Our findings suggested that these inflammatory markers, especially CRP, may initiate T2DM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health. Weekly Epidemiology Surveillance report. 2013;44:144–55. Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health. Weekly Epidemiology Surveillance report. 2013;44:144–55.
3.
go back to reference Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141–50.CrossRefPubMed Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141–50.CrossRefPubMed
4.
go back to reference Arora P, Garcia-Bailo B, Dastani Z, Brenner D, Villegas A, Malik S, et al. Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet. 2011;12:95.CrossRefPubMedPubMedCentral Arora P, Garcia-Bailo B, Dastani Z, Brenner D, Villegas A, Malik S, et al. Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet. 2011;12:95.CrossRefPubMedPubMedCentral
5.
go back to reference Belfki H, Ben Ali S, Bougatef S, Ben Ahmed D, Haddad N, Jmal A, et al. Association between C-reactive protein and type 2 diabetes in a Tunisian population. Inflammation. 2012;35:684–9.CrossRefPubMed Belfki H, Ben Ali S, Bougatef S, Ben Ahmed D, Haddad N, Jmal A, et al. Association between C-reactive protein and type 2 diabetes in a Tunisian population. Inflammation. 2012;35:684–9.CrossRefPubMed
6.
go back to reference Dongway AC, Faggad AS, Zaki HY, Abdalla BE. C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese. Diabetes Metab Syndr Obes. 2015;8:427–35.PubMedPubMedCentral Dongway AC, Faggad AS, Zaki HY, Abdalla BE. C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese. Diabetes Metab Syndr Obes. 2015;8:427–35.PubMedPubMedCentral
7.
go back to reference Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53(3):693–700.CrossRefPubMed Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53(3):693–700.CrossRefPubMed
8.
go back to reference Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K, et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: The Hisayama Study. Diabetes Care. 2005;28(10):2497–500.CrossRefPubMed Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K, et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: The Hisayama Study. Diabetes Care. 2005;28(10):2497–500.CrossRefPubMed
9.
go back to reference Aruna DP, JoAnn EM, Nader R, Julie EB, Paul MR. C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. J Am Med Assoc. 2001;286(3):327–34.CrossRef Aruna DP, JoAnn EM, Nader R, Julie EB, Paul MR. C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. J Am Med Assoc. 2001;286(3):327–34.CrossRef
10.
go back to reference Smitka K, Maresova D. Adipose Tissue as an Endocrine Organ: An Update on Pro-inflammatory and Anti-inflammatory Microenvironment. Prague Med Rep. 2015;116(2):87–111.CrossRefPubMed Smitka K, Maresova D. Adipose Tissue as an Endocrine Organ: An Update on Pro-inflammatory and Anti-inflammatory Microenvironment. Prague Med Rep. 2015;116(2):87–111.CrossRefPubMed
11.
go back to reference Ibfelt T, Fischer CP, Plomgaard P, van Hall G, Pedersen BK. The acute effects of low-dose TNF-alpha on glucose metabolism and beta-cell function in humans. Mediat Inflamm. 2014;2014:295478.CrossRef Ibfelt T, Fischer CP, Plomgaard P, van Hall G, Pedersen BK. The acute effects of low-dose TNF-alpha on glucose metabolism and beta-cell function in humans. Mediat Inflamm. 2014;2014:295478.CrossRef
12.
go back to reference Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–71.CrossRefPubMed Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–71.CrossRefPubMed
13.
go back to reference Popko K, Gorska E, Stelmaszczyk-Emmel A, Plywaczewski R, Stoklosa S, Gorecka D, et al. Proinflammatory cytokines IL-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res. 2010;15:120–2.PubMedPubMedCentral Popko K, Gorska E, Stelmaszczyk-Emmel A, Plywaczewski R, Stoklosa S, Gorecka D, et al. Proinflammatory cytokines IL-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res. 2010;15:120–2.PubMedPubMedCentral
15.
go back to reference Lukic L, Lalic NM, Rajkovic N, Jotic A, Lalic K, Milicic T, et al. Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention. Int J Environ Res Public Health. 2014;11(4):3586–98.CrossRefPubMedPubMedCentral Lukic L, Lalic NM, Rajkovic N, Jotic A, Lalic K, Milicic T, et al. Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention. Int J Environ Res Public Health. 2014;11(4):3586–98.CrossRefPubMedPubMedCentral
16.
go back to reference Xia W, Wei B, Jun L, Ying-Ying O, Di W, Shuang R, et al. Inflammatory markers and risk of type 2 diabetes: a systemic review and meta-analysis. Diabetes Care. 2013;36:166–75.CrossRef Xia W, Wei B, Jun L, Ying-Ying O, Di W, Shuang R, et al. Inflammatory markers and risk of type 2 diabetes: a systemic review and meta-analysis. Diabetes Care. 2013;36:166–75.CrossRef
17.
go back to reference Salmerón J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-independent diabetes mellitus in women. JAMA. 1997;277:472–7.CrossRefPubMed Salmerón J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-independent diabetes mellitus in women. JAMA. 1997;277:472–7.CrossRefPubMed
18.
go back to reference Ciok J, Dolna A. The role of glycemic index concept in carbohydrate metabolism. Przeql Lek. 2006;63(5):287–91. Ciok J, Dolna A. The role of glycemic index concept in carbohydrate metabolism. Przeql Lek. 2006;63(5):287–91.
19.
go back to reference Patel AV, McCullough ML, Pavluck AL, Jacobs EJ, Thun MJ, Calle EE. Glycemic load, glycemic index, and carbohydrate intake in relation to pancreatic cancer risk in a large US cohort. Cancer Cause Control. 2007;18(3):287–94.CrossRef Patel AV, McCullough ML, Pavluck AL, Jacobs EJ, Thun MJ, Calle EE. Glycemic load, glycemic index, and carbohydrate intake in relation to pancreatic cancer risk in a large US cohort. Cancer Cause Control. 2007;18(3):287–94.CrossRef
20.
go back to reference Raquel V, Simin L, Yu-Tang G, Gong Y, Honglan L, Wei Z, et al. Prospective Study of Dietary Carbohydrates, Glycemic Index, Glycemic Load, and Incidence of Type 2 Diabetes Mellitus in Middle-aged Chinese Women. Arch Intern Med. 2007;167(21):2310–6.CrossRef Raquel V, Simin L, Yu-Tang G, Gong Y, Honglan L, Wei Z, et al. Prospective Study of Dietary Carbohydrates, Glycemic Index, Glycemic Load, and Incidence of Type 2 Diabetes Mellitus in Middle-aged Chinese Women. Arch Intern Med. 2007;167(21):2310–6.CrossRef
21.
go back to reference Samasut R. Thai food exchange list. Thai J Parenter Enter Nutr. 2004;15:33–45. Samasut R. Thai food exchange list. Thai J Parenter Enter Nutr. 2004;15:33–45.
22.
go back to reference Atkinson FS, Foster-Powell K, Brand-Miller JC. International Tables of Glycemic Index and Glycemic Load Values: 2008. Diabetes Care. 2008;31 Atkinson FS, Foster-Powell K, Brand-Miller JC. International Tables of Glycemic Index and Glycemic Load Values: 2008. Diabetes Care. 2008;31
23.
go back to reference Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43:1575–81.CrossRefPubMed Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43:1575–81.CrossRefPubMed
24.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed
25.
go back to reference Fukuyama N, Homma K, Wakana N, Kudo K, Suyama A, Ohazama H, et al. Validation of the Friedewald Equation for Evaluation of Plasma LDL-Cholesterol. J Clin Biochem Nutr. 2008;43:1–5.CrossRefPubMed Fukuyama N, Homma K, Wakana N, Kudo K, Suyama A, Ohazama H, et al. Validation of the Friedewald Equation for Evaluation of Plasma LDL-Cholesterol. J Clin Biochem Nutr. 2008;43:1–5.CrossRefPubMed
26.
go back to reference Food and Drug Administration, U.S. Department of Health and Human Services. Guidance for industry and FDA staff: Review criteria for assessment of C-Reactive Protein (CRP), High Sensitivity C-Reactive protein (hsCRP) and Cardiac C-Reactive Protein (cCRP) Assays. 2005. https://www.fda.gov/MedicalDevices/ucm077167.htm. Accessed 2 Oct 2016. Food and Drug Administration, U.S. Department of Health and Human Services. Guidance for industry and FDA staff: Review criteria for assessment of C-Reactive Protein (CRP), High Sensitivity C-Reactive protein (hsCRP) and Cardiac C-Reactive Protein (cCRP) Assays. 2005. https://​www.​fda.​gov/​MedicalDevices/​ucm077167.​htm. Accessed 2 Oct 2016.
27.
go back to reference Bhupathiraju SN, Tobias DK, Malik VS, Pan A, Hruby A, Manson JE, et al. Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an update meta-analysis. Am J Clin Nutr. 2014;100:218–32.CrossRefPubMedPubMedCentral Bhupathiraju SN, Tobias DK, Malik VS, Pan A, Hruby A, Manson JE, et al. Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an update meta-analysis. Am J Clin Nutr. 2014;100:218–32.CrossRefPubMedPubMedCentral
28.
go back to reference Hopping BN, Erber E, Grandinetti A, Verheus M, Kolonel LN, Maskarinec G. Dietary fiber, Magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort Hawaii. J Nutr. 2010;140:68–74.CrossRefPubMedPubMedCentral Hopping BN, Erber E, Grandinetti A, Verheus M, Kolonel LN, Maskarinec G. Dietary fiber, Magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort Hawaii. J Nutr. 2010;140:68–74.CrossRefPubMedPubMedCentral
29.
go back to reference MosdØl A, Witte DR, Frost G, Marmot MG, Brunner EJ. Dietary glycemic index and glycemic load are associated with high density-lipoprotein cholesterol at baseline but not with increased risk of diabetes in Whitehall II study. Am J Clin Nutr. 2007;2007:988–94. MosdØl A, Witte DR, Frost G, Marmot MG, Brunner EJ. Dietary glycemic index and glycemic load are associated with high density-lipoprotein cholesterol at baseline but not with increased risk of diabetes in Whitehall II study. Am J Clin Nutr. 2007;2007:988–94.
30.
go back to reference van Woudenberg GJ, Kuijsten A, Sijbrands EJ, Hofman A, Witterman JC, Feskens EJ. Glycemic index and glycemic load and their association with C-reactive protein and incidenct type 2 diabetes. J Nutr Metab. 2011;2011:1–7.CrossRef van Woudenberg GJ, Kuijsten A, Sijbrands EJ, Hofman A, Witterman JC, Feskens EJ. Glycemic index and glycemic load and their association with C-reactive protein and incidenct type 2 diabetes. J Nutr Metab. 2011;2011:1–7.CrossRef
31.
go back to reference Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and Cardiovascular Disease: A Resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397–408.CrossRefPubMed Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and Cardiovascular Disease: A Resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397–408.CrossRefPubMed
32.
go back to reference Costagliola C, Romano V, De Tollis M, Aceto F, dell’Omo R, Romano MR, et al. TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm. 2013. doi:10.1155/2013/629529. Costagliola C, Romano V, De Tollis M, Aceto F, dell’Omo R, Romano MR, et al. TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm. 2013. doi:10.​1155/​2013/​629529.
33.
go back to reference Harder-Lauridsen NM, Krogh-Madsen R, Holst JJ, Plomgaard P, Leick L, Pedersen BK, et al. Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2014;306:769–78.CrossRef Harder-Lauridsen NM, Krogh-Madsen R, Holst JJ, Plomgaard P, Leick L, Pedersen BK, et al. Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2014;306:769–78.CrossRef
Metadata
Title
Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study
Authors
Chanchira Phosat
Pornpimol Panprathip
Noppanath Chumpathat
Pattaneeya Prangthip
Narisara Chantratita
Ngamphol Soonthornworasiri
Somchai Puduang
Karunee Kwanbunjan
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2017
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-017-0189-z

Other articles of this Issue 1/2017

BMC Endocrine Disorders 1/2017 Go to the issue